"A HIDDEN GEM AND LAGGARD BEHIND THE CONSTRUCTION SECTOR RALLY"
With the upcoming medium-term recovery plan that is going to be imposed by the government next month, as well as Budget 2021 and the 12th Malaysia Plan progressing, construction counters are moving up aggressively today, dated 7 September 2020.
Amongst the biggest winners for today's rally are:
INTA BINA GROUP BHD (0192)
EKOVEST BHD (8877)
ISKANDAR WATERFRONT CITY BHD (1589)
MAH SING GROUP BERHAD (8583)
GAMUDA BHD (5398)
SUNWAY CONSTRUCTION GROUP BHD (5263)
The list is not exclusive, but just to name a few of the outperformers in share price today.
These are the companies with either really bright prospects and direct / indirect beneficiaries for the revival of MRT 3 and HSR projects, or proxy for the projects. Companies that are fundamentally sound and strong like INTA BINA GROUP BHD and SUNWAY CONSTRUCTION GROUP BHD shown strong buyer interest in it as well.
So, who's the laggard and hidden gem for today?
The plain and simple answer is AGESON BHD (7145).
As per my article shared on 17 August 2020 titled "A new future - Ageson Berhad (7145)", I've clearly stated the investment merits of the company. And another seasoned accountant and investor in the forum emilysiew1 posted an article for the analysis of AGESON BHD's latest quarterly report results.
These are the links to the article for your perusal:
Based on our monitoring on the counter's share price, we understood that the company is trading at ridiculously low P/E ratio, and with it's increasing profitability, the share price shown no movement, yet.
So with the rally of construction stocks for today, AGESON BHD's share price should at least be increasing by 5 - 8 ticks! This company is being temporary forgotten and overlooked by investors. You may refer to INTA BINA GROUP BHD's share price movement. I strongly believe AGESON BHD will perform in the same matter.
Disclaimer: This article is purely for sharing and educational purposes. All investment decision should be made after due diligence and research and this article should and will not be served as a Buy or Sell Call.